Rosalba Caccavale
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort.
Journal: Frontiers in medicine
Published: February 18, 2026
Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis.
Journal: Rheumatology and therapy
Published: December 22, 2025
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter study.
Journal: BMC rheumatology
Published: June 25, 2025
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study.
Journal: Therapeutic advances in musculoskeletal disease
Published: June 23, 2025
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort.
Journal: Rheumatology and therapy
Published: June 20, 2025
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study.
Journal: Mediterranean journal of rheumatology
Published: May 11, 2025
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort Study.
Journal: Mediterranean journal of rheumatology
Published: May 11, 2025
Demographic Characteristics and Inflammatory Biomarker Profile in Psoriatic Arthritis Patients with Comorbid Fibromyalgia: A Cross-Sectional Study.
Journal: Medicina (Kaunas, Lithuania)
Published: April 29, 2025
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study.
Journal: Rheumatology advances in practice
Published: April 27, 2025
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter Study.
Journal: Medicina (Kaunas, Lithuania)
Published: September 28, 2024
Last Updated: 09/26/2026